Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Acura Pharmaceuticals, Inc.

TRADE

NASDAQ: ACURHealthcare / Drug Delivery / USA
0.28+0.084+42.71%Vol 15 2201Y Perf -33.33%
Oct 16th, 2018 15:59
BID0.00 ASK0.00
Open0.28 Previous Close0.196
Pre-Market- After-Trading-
 - -%  - -%
Target Price
6.00 
Analyst Rating
— 0.00
Potencial %
2 042.86 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
     23.57
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
     32.52
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)6 
Earnings Rating
Buy
Price Range Ratio 52wk %
23.37 
Earnings Date
12th Nov 2018

Today's Price Range

0.2010.28

 

52wk Range

0.100.87

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
118.75%
3 Months
-19.98%
6 Months
-49.09%
1 Year
-33.33%
3 Years
-90.00%
5 Years
-96.85%

Quotes

Name / TickerPriceChg.Chg.%
ACUR0.280.083842.71
AAPL222.154.79002.20
GOOG1 121.2829.03002.66
MSFT111.003.40003.16
XOM81.200.38000.47
WFC53.730.49000.92
JNJ136.562.61001.95
FB158.785.26003.43
GE12.10-0.0500-0.41
JPM108.622.28002.14
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.20
Current Ratio 0.20
Long Term Debt to Total Capital 0.30
Total Debt to Equity 2.26
Interest Coverage -14.00
Leverage Ratio -0.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin200.00
EBIT Margin-1 478.70
EBITDA Margin-1 412.50
Pre-tax Profit Margin-2 696.00
Profit Margin-36.20
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 5.58
PS Ratios 13.30
Price to Cash Flow 12.10
Price to Free Cash Flow -1.30
Cash Flow Per Share -0.28
Price to Tangible Book-1.76
Book Value per Share-0.12
Enterprise Value (in ths.)6 993
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-103.62
ROE last 12 Months 453.26
Return on Assets (5Y Avg) -190.00
ROA last 12 Months -145.59
Return on Capital (5Y Avg) -69.08
ROC last 12 Months -45.15
Return on invested Capital Q -45.15
Return on invested Capital Y-163.95
Assets Turnover0.00
Receivables Turnover2.20
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)348
Revenue per Share 0.02
Revenue Growth 3 Years -48.49
Revenue Growth 5 Years 71.15
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q04 2017--0.08-
Q03 2017--0.12-
Q02 2017-0.11-0.18-63.64
Q01 2017-0.110.03127.27
Q04 2016-0.270.13148.15
Q03 2016-0.27-0.1929.63
Q02 2016-0.28-0.280.00
Q01 2016-0.25-0.28-12.00
Earnings Per EndEstimateRevision %Trend
9/2017 QR-0.120.00-
12/2017 QR-0.120.00-
12/2017 FY-0.460.00-
12/2018 FY0.380.00-
Next Report Date12th Nov 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume15 220
Shares Outstanding (in ths.)21 030
Trades Count11
Dollar Volume3 787
Avg. Volume16 616
Avg. Weekly Volume10 384
Avg. Monthly Volume13 786
Avg. Quarterly Volume17 947

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

53%47%

Bearish Bullish

48%52%

Bearish Bullish

67%33%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News

x